Vishnu Lekraj, Morningstar senior equity analyst, discusses the role of the pharmacy benefit managers, or PBMs, and whether the "middlemen" are the ones to blame for drug price hikes.
Suzy Welch, LinkedIn contributing editor, discusses Mylan CEO Heather Bresch and what she had to say about the controversy surrounding Mylan's pricing of the EpiPen.
CNBC's Bertha Coombs reports Express Scripts earnings meeting expectations but revenues slightly missing. The company also raising its full-year guidance. Stephanie Link and Steve Grasso on the "Closing Bell" panel also weigh in.
CNBC's Seema Mody looks ahead at the busiest week in earnings season with 186 companies set to report. The "Closing Bell" panel weighs in on what they're watching next week.
Joseph Swedish, CEO at Anthem, talks about his company's on-going deal to buy Cigna, the outlook for Anthem in Obamacare exchanges, and working toward affordable drug prices.
"Power Lunch" hosts Melissa Lee and Brian Sullivan look at 5 stocks with analyst recommendations, including Telsey Advisory upgrading Cracker Barrel to outperform, and a bullish note on Salesforce.com.